Pfizer and Amgen are developing monthly GLP-1 shots with the goal being to make weight loss drugs more convenient and easier to maintain. Injections made by Wegovy and Zepbound are taken weekly. NBC News’ Berkeley Lovelace, Jr. explains how users may benefit.